4
Changes in Ownership
ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000008
CEO bought 46,000 shares at an average $0.03 ($1,188)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Collier Alan Brian CEO | 2019-01-30 | Purchase | +5,000 | $0.03 | $131 | 21,057,623 | D: show line 1 in the form |
| Collier Alan Brian CEO | 2019-01-30 | Purchase | +5,000 | $0.03 | $130 | 21,062,623 | D: show line 2 in the form |
| Collier Alan Brian CEO | 2019-01-30 | Purchase | +5,000 | $0.03 | $127 | 21,067,623 | D: show line 3 in the form |
| Collier Alan Brian CEO | 2019-01-30 | Purchase | +5,000 | $0.03 | $127 | 21,072,623 | D: show line 4 in the form |
| Collier Alan Brian CEO | 2019-01-30 | Purchase | +5,000 | $0.03 | $130 | 21,077,623 | D: show line 5 in the form |
| Collier Alan Brian CEO | 2019-01-30 | Purchase | +5,000 | $0.03 | $130 | 21,082,623 | D: show line 6 in the form |
| Collier Alan Brian CEO | 2019-01-31 | Purchase | +5,000 | $0.03 | $129 | 21,087,623 | D: show line 7 in the form |
| Collier Alan Brian CEO | 2019-01-31 | Purchase | +5,000 | $0.03 | $130 | 21,087,623 | D: show line 8 in the form |
| Collier Alan Brian CEO | 2019-01-31 | Purchase | +5,000 | $0.03 | $130 | 21,092,623 | D: show line 9 in the form |
| Collier Alan Brian CEO | 2019-01-31 | Purchase | +1,000 | $0.03 | $26 | 21,093,623 | D: show line 10 in the form |
| Open-market purchases · 46,000 sh · avg $0.03 · $1,188 | |||||||
Loading xslF345X03/primary_doc.xml…